{"id":3333,"date":"2010-09-17T11:47:55","date_gmt":"2010-09-17T15:47:55","guid":{"rendered":"http:\/\/blogs.nejm.org\/cardioexchange\/?p=3333"},"modified":"2011-07-19T17:44:49","modified_gmt":"2011-07-19T21:44:49","slug":"fda-grants-expanded-indication-to-crt-d-devices","status":"publish","type":"post","link":"https:\/\/blogs.nejm.org\/cardioexchange\/2010\/09\/17\/fda-grants-expanded-indication-to-crt-d-devices\/","title":{"rendered":"FDA Grants Expanded Indication to CRT-D Devices"},"content":{"rendered":"<p>The FDA has expanded the indication for CRT-D devices made by Boston Scientific. Previously, the devices had been approved only in NYHA Class III and IV patients. The expanded indication now includes Class I and II patients who have left bundle branch block. The expanded indication is based on data from the <a href=\"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMoa0906431\">MADIT-CRT trial<\/a>.<\/p>\n<p>\u201cThis approval allows heart failure patients with left bundle branch block to benefit from this therapy,&#8221; said Jeffrey Shuren, director of the FDA\u2019s Center for Devices and Radiological Health, in an <a href=\"http:\/\/www.fda.gov\/NewsEvents\/Newsroom\/PressAnnouncements\/ucm226123.htm\">FDA press release<\/a>. \u201cThe FDA is pleased to safely make this new technology available for a greater number of heart failure patients.&#8221;<\/p>\n","protected":false},"excerpt":{"rendered":"<p>The FDA has expanded the indication for CRT-D devices made by Boston Scientific. Previously, the devices had been approved only in NYHA Class III and IV patients. The expanded indication now includes Class I and II patients who have left bundle branch block. The expanded indication is based on data from the MADIT-CRT trial. \u201cThis [&hellip;]<\/p>\n","protected":false},"author":196,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13,1],"tags":[411,196,413,412],"class_list":["post-3333","post","type-post","status-publish","format-standard","hentry","category-electrophysiology","category-general","tag-crt-d","tag-fda","tag-lbbb","tag-madit-crt"],"_links":{"self":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/3333","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/users\/196"}],"replies":[{"embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/comments?post=3333"}],"version-history":[{"count":0,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/posts\/3333\/revisions"}],"wp:attachment":[{"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/media?parent=3333"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/categories?post=3333"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/blogs.nejm.org\/cardioexchange\/wp-json\/wp\/v2\/tags?post=3333"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}